Share Page:

Volume 28 , Issue 3
May/June 2013

Pages 749756

Evaluation of the Osteogenic Activity of the BMP-2 Mimetic Peptide, PEP7, In Vitro and In Vivo

Eun-Jung Kang, PhD/Su-Kyung Kim, MSc/Tae-Gwan Eom, MS, PhD/Kyoo-Ok Choi, DDS, MSD, PhD/Tae-Ho Lee, PhD

PMID: 23748305
DOI: 10.11607/jomi.2825

Purpose: To evaluate the osteogenic activity of a novel synthetic peptide, PEP7, derived from bone morphogenetic protein 2 (BMP-2) on MG-63, a human osteoblast-like cell line, and on new bone formation in vivo. Materials and Methods: The novel synthetic peptide was synthesized by a standard Fmoc method and purified to 98% purity. Cell adhesion, proliferation, and differentiation of MG-63 were observed in the presence of different concentrations of PEP7. Eight micropigs were used to evaluate new bone formation in a supra-alveolar peri-implant defect model. The PEP7-coated implants were randomly allocated to mandible defect sites. The animals were sacrificed after 8 weeks for histologic analysis. Results: PEP7 affected an early stage of adhesion and dose-dependently stimulated differentiation of MG-63 cells. The cell adhesion rate in the group coated with 1 μM PEP7 increased approximately 47% compared to the uncoated group and 32% compared to the group coated with recombinant human bone morphogenetic protein 2 (rhBMP-2) (P < .05). The alkaline phosphatase activities of groups treated with 50 μM of PEP7 were higher than for the other groups. PEP7 induced production of osteoblast-specific proteins in MG-63 cells. The largest effect was caused by 50 μM PEP7, followed by the groups treated with 20 μM synthetic peptide and 10 ng/mL rhBMP-2 (P < .05). Conclusions: A novel synthetic peptide derived from BMP-2 has osteoinductivity and new bone formation effects, including vertical augmentation of the alveolar ridge. Int J Oral Maxillofac Implants 2013;28:749756. doi: 10.11607/jomi.2825

Full Text PDF File | Order Article


Get Adobe Reader
Adobe Acrobat Reader is required to view PDF files. This is a free program available from the Adobe web site.
Follow the download directions on the Adobe web site to get your copy of Adobe Acrobat Reader.


© 2018 Quintessence Publishing Co, Inc JOMI Home
Current Issue
Ahead of Print
Author Guidelines
Submission Form
Quintessence Home
Terms of Use
Privacy Policy
About Us
Contact Us